Abstract

Objective: The present study was carried out to evaluate SSF process for the production of avermectin by Streptomyces avermitilis NRRL 8165 using easily available grains, millets and some agricultural by-product.Methods: Various substrates were screened for their ability to support avermectin production. Different parameters to maximize the yield of avermectin by S. avermitilis NRRL 8165 under SSF were optimized by conventional one factor at a time approach and parameters optimized earlier were adopted for the subsequent study.Results: Sorghum seeds used as solid substrate supported maximum growth and total avermectin production (4.6 mg g-1 dry substrate). The optimum values for maximum avermectin production were: moistening medium containing g l-1 KH2PO4 1; MgSO4.7H2O 0.4, inoculum size 20 % (24 h old culture in yeast extract-malt extract dextrose medium) v/w of initial dry substrate, substrate particle size 0.5 to 4 mm, incubation temperature 28 °C, initial moisture level 105%, incubation period of 15 d, 8 % w/w sucrose and 5% w/w soyameal. The avermectin yield with optimized fermentation condition was 5.8 mg g-1 dry substrate which is 1.3 fold higher as compared to non-optimized condition.Conclusion: Avermectin produced by S. avermitilis are widely used as an anthelmintic agent in the medical, veterinary and agricultural applications. In comparison with submerged fermentation, SSF can become an alternative cost-effective method for the production of avermectin. This report demonstrates the feasibility of employing agro-based substrate, that could reduce antibiotics production cost.

Highlights

  • Avermectin produced by Streptomyces avermitilis are 16-membered macrocyclic polyketides antibiotics [1]

  • The working cultures of the microorganism were prepared by cultivation on yeast extract-malt extract glucose (YMG) agar and incubated at 28 °C until sporulation occurred (4-6 d) and slants were stored at 4 °C

  • Different solid substrates viz. wheat bran, wheat rawa, sorghum, amaranth, pearl millet, barley, maize, potato and sawdust were screened for production of avermectin by S. avermitilis NRRL 8165

Read more

Summary

Introduction

Avermectin produced by Streptomyces avermitilis are 16-membered macrocyclic polyketides antibiotics [1]. It has broad-spectrum anthelmintic activity against nematodes and arthropod parasites [2]. Avermectin are exclusively produced by submerged fermentation (SmF) using mutants of S. avermitilis. Gao et al [4] reported 5.1 g l-1 avermectin B1a productions using a mutated organism S. avermitilis 14-12A at flask scale. These mutants are produced by various time and labourintensive methods [5]. Novak et al [7] reported instability in avermectin production, sporulation and pigmentation of S. avermitilis C-18/6 strain during subculturing. SmF has various disadvantages including a high volume of polluting effluent production, high volume and cost technology, high energy consumption, high risk of contamination, costly raw material, expensive bioreactor and complex downstream processing [8, 9]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.